Scopia Capital Management LP Mannkind Corp Transaction History
Scopia Capital Management LP
- $485 Billion
- Q3 2024
A detailed history of Scopia Capital Management LP transactions in Mannkind Corp stock. As of the latest transaction made, Scopia Capital Management LP holds 694,961 shares of MNKD stock, worth $4.88 Million. This represents 0.9% of its overall portfolio holdings.
Number of Shares
694,961
Previous 694,961
-0.0%
Holding current value
$4.88 Million
Previous $3.63 Billion
20.5%
% of portfolio
0.9%
Previous 0.54%
Shares
10 transactions
Others Institutions Holding MNKD
# of Institutions
244Shares Held
148MCall Options Held
1.62MPut Options Held
802K-
Black Rock Inc. New York, NY22.6MShares$158 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.6MShares$110 Million0.0% of portfolio
-
State Street Corp Boston, MA9.6MShares$67.4 Million0.0% of portfolio
-
Nitorum Capital, L.P. New York, NY9.16MShares$64.3 Million6.38% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.75MShares$61.4 Million0.83% of portfolio
About MANNKIND CORP
- Ticker MNKD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 257,338,000
- Market Cap $1.81B
- Description
- MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...